Theriana Pharmaceuticals
Waltham, US · Founded 2017 · Delaware corporation
Founders & leadership
DS
Daniel S. GrauNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.8M disclosed across 1 round · 2017
▶$1.8MraisedJul 2017 · 2 investors · PharmaceuticalsRule 506(b)
▶$1.8MraisedJul 2017 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Daniel S. GrauExecutive Officer, Director
- Offering amount
- $7M
- Amount sold
- $1.8M
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Theriana Pharmaceuticals raised?
- Theriana Pharmaceuticals has disclosed $1.8M raised across 1 round.
- Where is Theriana Pharmaceuticals headquartered?
- Theriana Pharmaceuticals is headquartered in Waltham, US.